altoslabs.comHealthcare / BioTech & PharmaFounded: 2021Funding to Date: $11.13B
Altos Labs is an American biotechnology research company founded in 2022 and focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine. Altos has operations in San Francisco, San Diego, and in Cambridge, UK, with significant collaborations in Japan, with a Board of Directors and advisors including Nobel Laureates and scientific leaders.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
02/14/2024 | Series C | $1.5B | $xx.xx | $6.33B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
59,781,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/25/2022 | Series B | $818.78MM | $xx.xx | $3.67B | Arch Venture Partners, Mubadala Investment Company | |
Price per Share
$xx.xx
Shares Outstanding
42,759,506
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Arch Venture Partners, Mubadala Investment Company
|
||||||
09/04/2021 | Series A | $305.91MM | $xx.xx | $1.33B | Jeff Bezos, Yuri Milner | |
Price per Share
$xx.xx
Shares Outstanding
34,102,438
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Jeff Bezos, Yuri Milner
|